GR79479B - - Google Patents

Info

Publication number
GR79479B
GR79479B GR73259A GR830173259A GR79479B GR 79479 B GR79479 B GR 79479B GR 73259 A GR73259 A GR 73259A GR 830173259 A GR830173259 A GR 830173259A GR 79479 B GR79479 B GR 79479B
Authority
GR
Greece
Application number
GR73259A
Other languages
Greek (el)
Inventor
G Doria
C Passarotti
A Buttinoni
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838329746A external-priority patent/GB8329746D0/en
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of GR79479B publication Critical patent/GR79479B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR73259A 1982-12-23 1983-12-15 GR79479B (instruction)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8236642 1982-12-23
GB838329746A GB8329746D0 (en) 1983-11-08 1983-11-08 Carboxamido-derivatives

Publications (1)

Publication Number Publication Date
GR79479B true GR79479B (instruction) 1984-10-30

Family

ID=26284768

Family Applications (1)

Application Number Title Priority Date Filing Date
GR73259A GR79479B (instruction) 1982-12-23 1983-12-15

Country Status (15)

Country Link
US (1) US4522944A (instruction)
AT (1) AT385036B (instruction)
AU (1) AU558600B2 (instruction)
CA (1) CA1211440A (instruction)
CH (1) CH657136A5 (instruction)
DE (1) DE3346223A1 (instruction)
DK (1) DK593983A (instruction)
FI (1) FI834698A7 (instruction)
FR (1) FR2538392B1 (instruction)
GR (1) GR79479B (instruction)
IL (1) IL70522A (instruction)
IT (1) IT1194521B (instruction)
NL (1) NL8304340A (instruction)
SE (1) SE454698B (instruction)
SU (1) SU1297731A3 (instruction)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702758A1 (de) * 1987-01-30 1988-09-29 Hoechst Ag Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
KR102065319B1 (ko) 2007-03-12 2020-01-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 치환된 헤테로환 융합 감마-카르볼린 합성
WO2013155504A1 (en) 2012-04-14 2013-10-17 Intra-Cellular Therapies, Inc. Novel methods
WO2014145192A1 (en) 2013-03-15 2014-09-18 Intra-Cellular Therapies, Inc. Organic compounds
CN105939712A (zh) 2013-12-03 2016-09-14 细胞内治疗公司 新方法
KR20170012210A (ko) 2014-04-04 2017-02-02 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
US9745300B2 (en) 2014-04-04 2017-08-29 Intra-Cellular Therapies, Inc. Organic compounds
KR20240170975A (ko) 2016-01-26 2024-12-05 인트라-셀룰라 써래피스, 인코퍼레이티드. 유기 화합물
US11014925B2 (en) 2016-03-28 2021-05-25 Intra-Cellular Therapies, Inc. Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
EP3436083A4 (en) 2016-03-28 2019-11-27 Intra-Cellular Therapies, Inc. NOVEL COMPOSITIONS AND METHOD
EP3436455A4 (en) 2016-03-28 2019-09-04 Intra-Cellular Therapies, Inc. NOVEL SALTS AND CRYSTALS
EP3525763B1 (en) 2016-10-12 2025-03-05 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
WO2018126140A1 (en) 2016-12-29 2018-07-05 Intra-Cellular Therapies, Inc. Organic compounds
US10906906B2 (en) 2016-12-29 2021-02-02 Intra-Cellular Therapies, Inc. Organic compounds
IL268970B2 (en) 2017-03-24 2023-12-01 Intra Cellular Therapies Inc Oral preparations of heterocyclic gamma carboline derivatives fused for absorption through mucous membranes
CN111093664B (zh) 2017-07-26 2023-06-02 细胞内治疗公司 有机化合物
CA3071119A1 (en) 2017-07-26 2019-01-31 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment or prophylaxis of central nervous system disorders
WO2019183341A1 (en) 2018-03-23 2019-09-26 Intra-Cellular Therapies, Inc. Organic compounds
CN112384218B (zh) 2018-06-06 2024-04-26 细胞内治疗公司 盐和晶体
EP3801527B1 (en) 2018-06-08 2025-02-19 Intra-Cellular Therapies, Inc. Fused gamma-carbolines for acute treatment of anxiety or depression
WO2019241278A1 (en) 2018-06-11 2019-12-19 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines synthesis
US12144808B2 (en) 2018-08-29 2024-11-19 Intra-Cellular Therapies, Inc. Compositions and methods
KR20210052472A (ko) 2018-08-31 2021-05-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CA3108553A1 (en) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Novel methods
CN114072150A (zh) 2019-07-07 2022-02-18 细胞内治疗公司 新方法
US11753419B2 (en) 2019-12-11 2023-09-12 Intra-Cellular Therapies, Inc. 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)phenyl)butan-1-one for treating conditions of the central nervous system and cardiac disorders
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5129981B2 (instruction) * 1973-07-17 1976-08-28
GB1568962A (en) * 1975-10-31 1980-06-11 Beecham Group Ltd Reparation and compositions containing them (heterocyclic-carbonylamino)pencillins methods for their p
JPS55115889A (en) * 1979-02-28 1980-09-06 Teijin Ltd 6-carbamoylthiazolo 3,2-a pyrimidine derivative and its preparation
JPS57142989A (en) * 1981-02-27 1982-09-03 Dai Ichi Seiyaku Co Ltd Thiazolopyrimidine derivative

Also Published As

Publication number Publication date
AT385036B (de) 1988-02-10
SE8307133D0 (sv) 1983-12-22
SU1297731A3 (ru) 1987-03-15
DE3346223A1 (de) 1984-06-28
SE8307133L (sv) 1984-06-24
CA1211440A (en) 1986-09-16
AU2252583A (en) 1984-06-28
IL70522A (en) 1986-02-28
AU558600B2 (en) 1987-02-05
FR2538392B1 (fr) 1987-01-16
CH657136A5 (de) 1986-08-15
ATA438383A (de) 1987-07-15
NL8304340A (nl) 1984-07-16
DK593983D0 (da) 1983-12-22
FR2538392A1 (fr) 1984-06-29
DK593983A (da) 1984-06-24
FI834698A7 (fi) 1984-06-24
IL70522A0 (en) 1984-03-30
SE454698B (sv) 1988-05-24
IT1194521B (it) 1988-09-22
US4522944A (en) 1985-06-11
IT8324207A0 (it) 1983-12-16
FI834698A0 (fi) 1983-12-20

Similar Documents

Publication Publication Date Title
FR2519857B1 (instruction)
FR2519777B1 (instruction)
FR2519617B3 (instruction)
FR2521034B1 (instruction)
GR79479B (instruction)
FR2520076B1 (instruction)
FR2519689B1 (instruction)
CH655464B (instruction)
FR2520133B1 (instruction)
FR2520664B1 (instruction)
FR2520430B1 (instruction)
FR2519606B3 (instruction)
GR79317B (instruction)
FR2526249B1 (instruction)
FR2520824B3 (instruction)
FR2519745B3 (instruction)
FR2520081B3 (instruction)
CH655636B (instruction)
FR2519796B1 (instruction)
FR2520716B1 (instruction)
FR2520594B1 (instruction)
CH656692B (instruction)
CH655455B (instruction)
FR2519805B1 (instruction)
FR2520427B3 (instruction)